Sphera Funds Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Sphera Funds Management’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-951,600	Closed	-$4.74M	–	122
2019 Q1	$4.74M	Buy	951,600 +20,000	+2%	+$98.5K	0.43%	52
2018 Q4	$4.17M	Sell	931,600 -247,410	-21%	-$1.21M	0.47%	48
2018 Q3	$5.72M	Buy	1,179,010 +505,014	+75%	+$2.58M	0.66%	39
2018 Q2	$4.04M	Buy	+673,996	New	+$4.93M	0.56%	53
2016 Q2	–	Sell	-60,718	Closed	-$277K	–	116
2016 Q1	$277K	Sell	60,718 -121,100	-67%	-$546K	0.06%	87
2015 Q4	$1.38M	Buy	+181,818	New	+$1.31M	0.2%	101

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sphera Funds Management's SBBP Position: Q2 2019 in Review

Sphera Funds Management sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2019, closing a stake of 951,600 shares — an estimated $4.74M sold.

Sphera Funds Management first reported a position in SBBP in Q4 2015 and held it in 6 quarters. The position peaked at $5.72M in Q3 2018. 58 funds tracked by Wall St. Rank hold SBBP as of Q2 2019.

Sphera Funds Management reported no remaining Strongbridge Biopharma plc. position as of Q2 2019 after selling out during the quarter.
Sphera Funds Management sold 951,600 Strongbridge Biopharma plc. shares in Q2 2019, an estimated $4.74M.
Sphera Funds Management first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 6 quarters.
Sphera Funds Management's Strongbridge Biopharma plc. position peaked at $5.72M in Q3 2018.
58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.